Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension

NCT00311155 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

694

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessary

Sponsor

Sankyo Pharma Gmbh